LOGIN  |  REGISTER
Amneal Pharmaceuticals
Cue Biopharma

Universal Health Services Announces Date For Third Quarter 2024 Earnings Release And Conference Call

October 02, 2024 | Last Trade: US$197.61 0.09 0.05

KING OF PRUSSIA, Pa., Oct. 2, 2024 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that it will report results for its third quarter ended September 30, 2024, after the market closes on Thursday, October 24, 2024. There will be a conference call for investors and analysts at 9:00 a.m. Eastern Time on Friday, October 25, 2024.

A live webcast of the call will be available on the company's website at www.uhs.com. To participate via telephone, please register in advance at this link.  Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call. A replay of the call will be available for one full year following the live call.

Universal Health Services, Inc. is one of the nation's largest hospital companies, operating through its subsidiaries, acute care hospitals, behavioral health facilities and ambulatory centers located throughout the United States, the United Kingdom, and Puerto Rico. 

Stock Quote

Featured Stock

ClearPoint Neuro

ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...

CLICK TO LEARN MORE

Featured Stock

Chimerix

Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB